Skip to main content

THE HEART RESEARCH INSTITUTE LTD

Registered charityABN active since 18 Apr 2000ASIC: Registered

Health Promotion Charity · Australian public company · Limited by guarantee · Newtown NSW 2042

Charity · LargeDGRHPC
ABN
41 003 209 952Active since 18 Apr 2000
ACN
003 209 952Registered 10 Dec 1986
Charity size
LargeRegistered with ACNC 3 Dec 2012
Revenue
$24.2mYear to 31 Dec 2024
Employees
103Reported for 2024–25
Location
NSW 2042Main business location

Registration

Legal name
THE HEART RESEARCH INSTITUTE LTD
ABN
41 003 209 952 Active from 18 Apr 2000
ACN
003 209 952
Entity type
Australian Public Company
ASIC status
Registered
ASIC type
Australian public company · Limited by guarantee · Unlisted public non-profit company
Registered
10 Dec 1986
Previous state registration
NSW · 38498243
GST
Registered from 1 Jul 2000
DGR
Endorsed from 1 Jul 2000
Main business location
NSW 2042

Charity

Charity name
The Heart Research Institute Ltd
Subtype
Health Promotion Charity (HPC)
Size
Large
Registered with ACNC
3 Dec 2012
Established
1 Jan 1986
Financial year end
31 December
Operates in
New South Wales · Australia only
Responsible persons
12 · names on the ACNC Register
Website
hri.org.au

Who it helps

  • General community in Australia

Purposes

  • Advancing health

Charity finances

Reporting period
1 Jan 2024 – 31 Dec 2024
Total revenue
$24,206,191
Revenue sources
Government $7,763,439 · Donations and bequests $13,822,038 · Investments $1,339,345 · Other $1,281,369
Total expenses
$24,678,357
Expenses
Employees $12,056,221 · Other $12,622,136
Net surplus or deficit
$37,356
Total assets
$45,511,644
Total liabilities
$16,682,960
Net assets
$28,828,684
Staff
74 full-time · 30 part-time · 13 casual · 91.3 full-time equivalent
Volunteers
0
Key management personnel
7

Earlier years

Period endingRevenueExpensesNet surplus
31 Dec 2023$21,314,183$26,392,460−$4,550,856
31 Dec 2022$20,723,182$25,210,897−$5,221,253
Fundraising registrations (6 states and territories)
  • Australian Capital Territory · 19000610
  • New South Wales · 13934
  • Queensland · CH1695
  • South Australia · CCP3031
  • Tasmania · F1A-58
  • Victoria · 11057.19

Business names (6)

NameStatusRegistered
Djurali Centre for Aboriginal and Torres Strait Islander Health Research and EducationRegistered25 Mar 2025
Sydney Cardiovascular Research CentreRegistered20 Sep 2016
Hearts for EternityRegistered12 Feb 2016
HERO OF THE HEARTRegistered28 Aug 2009
INTERNATIONAL HEART RESEARCH INSTITUTERegistered27 Mar 2002
HEART RESEARCH INSTITUTE AUSTRALIARegistered27 Jul 1999
Former and other names (1)
  • THE HEART RESEARCH INSTIT LTDTrading name (ABR; not updated by the ABR since 2012)

Workforce

Reporting year
2024–25
Employees
103
Women and men
68 women (66%) · 35 men (34%)
Managers
36 · 21 women (58%) · 15 men (42%)
Employment
72 full-time · 21 part-time · 10 casual
Employer size
<250 employees
Industry
Scientific Research Services · ANZSIC 6910
Corporate group
The Heart Research Institute Ltd

Numbers are for the whole organisation in the reporting year.

Trade marks, patents and designs (61)

Trade marks 11

Trade markStatusFiled
FLUXOMICS CENTRENo. 2386270 · Classes 9, 36, 41, 42, 44Protected6 Sep 2023
HELPING EVERY HEARTNo. 2375469 · Classes 9, 36, 41, 42, 44Protected27 Jul 2023
Hearts for EternityNo. 1752361 · Class 42Protected15 Feb 2016
HERO OF THE HEARTNo. 1389413 · Classes 28, 36, 41Protected19 Oct 2010
HRI HEART RESEARCH INSTITUTENo. 1017079 · Classes 10, 36, 42Protected23 Aug 2004
HRINo. 1017078 · Classes 10, 36, 42Protected23 Aug 2004
HEART RESEARCH INSTITUTE AUSTRALIANo. 801518 · Classes 10, 36Protected26 Jul 1999
Image markNo. 793648 · Classes 9, 10, 29, 30, 36Protected10 May 1999
No longer current (3)
Trade markStatusFiled
SUPPORTING AUSTRALIANo. 793646 · Class 36Ceased10 May 200910 May 1999
CARING TOGETHERNo. 787486 · Class 36Ceased4 Mar 20094 Mar 1999
HEART THROBNo. 773698 · Classes 28, 36Ceased21 Sep 201821 Sep 1998

Patents 50

TitleStatusFiled
Proteolysis targeting chimerasNo. 2026909064 · ProvisionalFiled4 Nov 2026
Combination Therapies for Treating CancerNo. 2026905040 · ProvisionalFiled27 May 2026
CompoundsNo. 2026900691 · ProvisionalFiled28 Jan 2026
NEW SYNTHESIS METHODNo. 2024312719Filed9 Jan 2026
System for producing microfluidic chipsNo. 2025906578 · ProvisionalFiled18 Dec 2025
Detection of high-risk unstable atherosclerotic plaqueNo. 2025905489 · ProvisionalFiled14 Nov 2025
A MICROFLUIDIC DEVICE AND A METHOD OF FORMING THEREOFNo. 2024233284Filed23 Sep 2025
Improved thrombin inhibitors for treatment of thromboembolic conditionsNo. 2020453661Granted8 Dec 2022
Treatment of thrombosis and associated disorders with an anti-platelet agentNo. 2021271402Filed23 Nov 2022
Detection of high-risk unstable atherosclerotic plaqueNo. 2019312038Granted15 Feb 2021
Thrombin inhibitors for treatment of stroke and related coagulative disordersNo. 2017376839Granted21 Jun 2019
No longer current (39)
TitleStatusFiled
Antithrombotic peptidesNo. 2025901736 · ProvisionalLapsed7 May 20267 May 2025
A microfluidic device for modelling vasculature activity and a method of forming thereofNo. 2025900592 · ProvisionalLapsed28 Feb 202628 Feb 2025
Peripheral artery diseaseNo. 2024903209 · ProvisionalLapsed3 Oct 20253 Oct 2024
Method of determining drug toxicityNo. 2024902481 · ProvisionalLapsed9 Aug 20259 Aug 2024
Microfluidic devicesNo. 2024900360 · ProvisionalLapsed15 Feb 202515 Feb 2024
Peripheral artery diseaseNo. 2023902349 · ProvisionalLapsed6 Sep 202424 Jul 2023
New synthesis methodNo. 2023901984 · ProvisionalLapsed2 Aug 202423 Jun 2023
Peripheral artery diseaseNo. 2023901224 · ProvisionalLapsed7 Jun 202426 Apr 2023
A microfluidic device and a method of forming thereofNo. 2023900588 · ProvisionalLapsed3 May 20246 Mar 2023
Sleep apnoea diagnosticNo. 2022900912 · ProvisionalLapsed2 Jun 20237 Apr 2022
Sleep apnoea diagnosticNo. 2021901952 · ProvisionalLapsed5 Aug 202228 Jun 2021
Treatment methods for pulmonary arterial hypertensionNo. 2021900882 · ProvisionalLapsed6 May 202225 Mar 2021
Treatment of thrombosis and associated disorders with an anti-platelet agentNo. 2020901559 · ProvisionalLapsed2 Jul 202114 May 2020
Treatment of thrombosis and associated disorders with an anti-platelet agentNo. 2020901558 · ProvisionalLapsed2 Jul 202114 May 2020
Plasma Polymer Nanoparticles carrying agentsNo. 2019900427 · ProvisionalLapsed3 Apr 202011 Feb 2019
Plasma polymerisation apparatusNo. 2018903344 · ProvisionalLapsed1 Nov 20197 Sep 2018
Detection of unstable atherosclerotic plaqueNo. 2018902699 · ProvisionalLapsed6 Sep 201925 Jul 2018
Medical devices with reduced thrombogenicityNo. 2015316192Ceased26 Mar 202117 Mar 2017
NanoparticlesNo. 2016905306 · ProvisionalLapsed2 Feb 201821 Dec 2016
Thrombin inhibitors for treatment of stroke and related coagulative disordersNo. 2016905231 · ProvisionalLapsed2 Feb 201816 Dec 2016
Tumour Necrosis Factor TNF-Related Apoptosis-Inducing Ligand Trail Compositions and Methods for Treating Wound HealingNo. 2015904008 · ProvisionalLapsed4 Nov 20161 Oct 2015
Method of cell differentiation and uses therefor in screening diagnosis and therapyNo. 2010225438Lapsed22 Sep 201421 Sep 2011
Seleno-Compounds and Therapeutic Uses ThereofNo. 2010904801 · ProvisionalLapsed2 Dec 201128 Oct 2010
Method of cell differentiation and uses therefor in screening diagnosis and therapyNo. 2009905195 · ProvisionalLapsed3 Dec 201023 Oct 2009
Combination therapyNo. 2009905152 · ProvisionalLapsed3 Dec 201022 Oct 2009
Method of cell differentiation and uses therefor in screening diagnosis and therapyNo. 2009901166 · ProvisionalLapsed7 May 201017 Mar 2009
Compositions and methods for treating cardiovascular disordersNo. 2001272191Lapsed19 Jan 200729 Jan 2003
Oxidized apolipoproteins and methods of useNo. 2001016818Ceased27 Jul 200617 May 2002
Iron chelators and uses thereofNo. 2000073922Ceased23 Apr 20098 Mar 2002
Cyclodextrins and reversal of atherosclerosisNo. 2000901783 · ProvisionalLapsed29 Nov 2000
Method for collecting and identifying markers of coronary diseaseNo. 2000066702Ceased15 Jun 200625 Oct 2000
Compositions and methods for treating cardiovascular disordersNo. 2000908728 · ProvisionalLapsed12 Jul 2000
Oxidized apolipoproteins and methods of useNo. 1999904293 · ProvisionalLapsed26 Nov 1999
Method for collecting and identifying markers of coronary diseaseNo. 1999903734 · ProvisionalLapsed28 Oct 1999
Atherosclerosis related therapiesNo. 1999901205 · ProvisionalLapsed25 Jun 1999
A method for detection of potential co-antioxidantsNo. 1997024176Ceased30 Nov 20066 Oct 1998
Novel chemotactic factorNo. 1991085040Ceased14 Apr 20054 Mar 1993
Novel chemotactic factorNo. 1991904463 · ProvisionalLapsed5 Feb 1991
Novel chemotactic factorNo. 1990902127 · ProvisionalLapsed5 Sep 1990

Current means registered, granted or still being examined. Applications are listed by filing date, newest first.

History

  1. 25 Mar 2025
    Business name Djurali Centre for Aboriginal and Torres Strait Islander Health Research and Education registeredASIC business names
  2. 20 Sep 2016
    Business name Sydney Cardiovascular Research Centre registeredASIC business names
  3. 12 Feb 2016
    Business name Hearts for Eternity registeredASIC business names
  4. 3 Dec 2012
    Registered with the ACNCACNC
  5. 28 Aug 2009
    Business name HERO OF THE HEART registeredASIC business names
  6. 27 Mar 2002
    Business name INTERNATIONAL HEART RESEARCH INSTITUTE registeredASIC business names
  7. 1 Jul 2000
    Endorsed as a deductible gift recipient (DGR)ABR
  8. 1 Jul 2000
    Registered for GSTABR
  9. 18 Apr 2000
    ABN activeABR
  10. 27 Jul 1999
    Business name HEART RESEARCH INSTITUTE AUSTRALIA registeredASIC business names
  11. 10 Dec 1986
    Registered with ASIC (NSW 38498243)ASIC

We record changes every week from 20 Nov 2026. Earlier dates come from each register.

Related

Other charities in 2042

All businesses in postcode 2042 →

Same industry (ANZSIC 6910, Scientific Research Services)

All employers in this industry →

Similar names (not necessarily related)